Saturday 17 October 2026
Export KMDA’s income statement to Excel — free account
Kamada Ltd.
KMDA Healthcare Drug Manufacturers Specialty & Generic
Kamada Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $180.5 million, up 12.1% from fiscal 2024. In the quarter to June 2026, revenue grew 22.7%, EPS grew 23.1%, free cash flow grew 165.7% and total debt fell 38.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
7.77
0.06
−0.77%
Follow KMDA
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
20.17 | 23.42 | 38.50 | 0.00 | 0.00 | 16.62 | 12.65 | 9.09 | 28.24 | 0.00 |
Piotroski F-Score |
7 | 8 | 7 | 6 | 0 | 5 | 5 | 6 | 7 | 5 |
P/S ratio |
2.26 | 2.18 | 2.11 | 1.44 | 2.84 | 2.15 | 2.17 | 1.76 | 1.77 | 2.75 |
Altman Z-Score |
3.33 | 2.81 | 2.36 | 1.21 | 1.65 | 6.87 | 5.73 | 5.90 | 3.83 | 3.24 |
Altman Z″-Score (non-manufacturers) |
5.42 | 4.93 | 4.36 | 2.16 | 2.39 | 10.55 | 7.61 | 7.71 | 4.12 | 1.39 |
P/FCF ratio |
26.00 | 9.50 | 0.00 | 7.50 | 0.00 | 20.99 | 10.89 | 26.18 | 0.00 | 0.00 |
Beneish M-Score |
(2.35) | (2.90) | (2.57) | (3.30) | 3.88 | (2.34) | (2.40) | 13.72 | (1.98) | (3.36) |
P/Operating CF |
53.79 | 33.67 | 68.21 | 27.59 | (59.29) | 22.44 | 31.80 | 31.61 | 49.37 | 84.21 |
Dividend Safety Score |
50 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.51 | 1.35 | 1.23 | 1.06 | 1.67 | 1.60 | 2.04 | 1.79 | 2.04 | 3.19 |
Price to Tangible BV |
1.70 | 1.53 | 1.41 | 6.51 | 13.02 | 1.60 | 2.04 | 1.79 | 2.04 | 3.19 |
EV/Sales |
1.95 | 1.82 | 1.90 | 1.54 | 3.03 | 1.33 | 1.59 | 1.33 | 1.37 | 2.40 |
EV/EBITDA |
8.56 | 8.64 | 11.89 | 11.92 | 63.92 | 7.34 | 7.41 | 6.62 | 12.88 | 0.00 |
EV/Operating CF |
13.82 | 6.15 | 62.78 | 6.96 | (35.61) | 9.27 | 7.33 | 14.41 | 39.14 | 98.15 |
EV/FCF |
22.50 | 7.94 | (177.28) | 8.02 | (25.02) | 12.99 | 8.00 | 19.75 | (283.02) | (265.24) |
Quick Ratio |
2.28 | 2.14 | 1.64 | 0.93 | 1.16 | 5.44 | 3.07 | 3.46 | 2.58 | 1.89 |
Current Ratio |
4.07 | 3.73 | 3.43 | 1.84 | 2.41 | 7.13 | 4.39 | 4.70 | 3.30 | 2.83 |
Net Debt/EBITDA |
(1.59) | (2.02) | (1.78) | 0.77 | 3.96 | (4.52) | (2.68) | (2.15) | (3.74) | 13.56 |
Debt/Assets |
2.62% | 2.73% | 4.23% | 14.61% | 11.93% | 0.13% | 0.43% | 0.83% | 1.62% | 1.78% |
Debt/Equity |
0.04 | 0.04 | 0.06 | 0.27 | 0.22 | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 |
Asset Turnover |
0.48 | 0.44 | 0.42 | 0.40 | 0.39 | 0.69 | 0.82 | 0.88 | 0.93 | 0.77 |
Operating CF/Net income |
1.26 | 3.29 | 0.52 | (12.32) | 3.95 | 1.11 | 1.24 | 0.47 | 0.52 | (0.28) |
Capex/Depreciation |
(0.66) | (0.78) | (0.46) | (0.31) | (0.66) | (1.12) | (0.51) | (0.77) | (1.17) | (0.74) |
Interest Coverage |
30.36 | 30.38 | 7.75 | 4.96 | (2.46) | 72.32 | 77.76 | 111.97 | 45.95 | (43.50) |
| 7.64% | 5.74% | 3.94% | (1.32%) | (1.25%) | 10.92% | 17.97% | 22.09% | 8.83% | (9.67%) | |
| 5.38% | 3.98% | 2.45% | (0.72%) | (0.84%) | 8.92% | 14.27% | 17.14% | 6.22% | (6.68%) | |
ROIC |
8.06% | 6.55% | 3.09% | 1.50% | (0.22%) | 17.26% | 22.91% | 19.13% | 9.60% | (8.59%) |
Return on Tangible Assets |
10.80% | 8.45% | 5.57% | (2.59%) | (2.18%) | 9.60% | 16.44% | 19.85% | 7.45% | (9.29%) |
Average Days of Receivables |
66.06 | 61.44 | 66.18 | 101.49 | 155.08 | 72.95 | 76.00 | 98.79 | 116.41 | 107.63 |
Research and Development Expense of Revenue |
7.20% | 9.43% | 9.78% | 10.18% | 10.96% | 10.21% | 10.27% | 8.51% | 11.64% | 20.96% |
Selling, General and Administrative Expense of Revenue |
20.60% | 21.20% | 21.45% | 21.72% | 18.25% | 11.00% | 10.66% | 10.62% | 12.32% | 13.67% |
Intangible Assets out of Total Assets |
0.08 | 0.08 | 0.09 | 0.46 | 0.48 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.47% | 0.54% | 0.92% | 0.89% | 0.51% | 0.73% | 0.91% | 0.83% | 0.47% | 1.38% |
Graham Net Nets |
0.21 | 0.20 | 0.20 | (0.04) | (0.04) | 0.51 | 0.38 | 0.42 | 0.35 | 0.21 |
Graham Number |
6.06 | 5.14 | 4.24 | 0.00 | 0.00 | 5.96 | 6.39 | 5.88 | 3.00 | 0.00 |
Earnings Yield |
4.96% | 4.27% | 2.60% | (1.20%) | (0.76%) | 6.02% | 7.91% | 11.00% | 3.54% | (3.08%) |
Free Cash Flow Yield |
3.85% | 10.53% | (0.51%) | 13.34% | (4.26%) | 4.76% | 9.18% | 3.82% | (0.27%) | (0.33%) |
Revenue per Share |
3.13 | 2.80 | 2.92 | 2.89 | 2.31 | 3.02 | 3.15 | 2.84 | 2.71 | 2.13 |
Operating CF per Share |
0.44 | 0.83 | 0.09 | 0.64 | (0.20) | 0.43 | 0.68 | 0.26 | 0.10 | 0.05 |
Capex per Share |
(0.17) | (0.19) | (0.12) | (0.08) | (0.08) | (0.12) | (0.06) | (0.07) | (0.11) | (0.07) |
Free Cash Flow per Share |
0.27 | 0.64 | (0.03) | 0.55 | (0.28) | 0.31 | 0.63 | 0.19 | (0.01) | (0.02) |
Cash per Share |
1.31 | 1.36 | 1.14 | 0.76 | 0.42 | 2.48 | 1.83 | 1.26 | 1.13 | 0.79 |
Shareholders Equity per Share |
4.67 | 4.51 | 5.00 | 3.93 | 3.95 | 4.05 | 3.36 | 2.79 | 2.36 | 1.83 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.67 | 4.51 | 5.00 | 3.93 | 3.95 | 4.05 | 3.36 | 2.79 | 2.36 | 1.83 |
Free Cash Flow |
15.65 | 36.86 | (1.53) | 24.80 | (12.55) | 13.62 | 25.28 | 7.69 | (0.50) | (0.70) |
Working Capital |
145.68 | 134.96 | 120.37 | 63.30 | 75.99 | 152.95 | 110.82 | 87.32 | 67.49 | 49.87 |
Capital Expenditures |
(9.84) | (10.74) | (5.84) | (3.78) | (3.73) | (5.48) | (2.29) | (2.85) | (4.11) | (2.60) |
Net Current Asset Value |
83.44 | 71.56 | 59.08 | (7.35) | (11.80) | 145.89 | 105.08 | 85.15 | 64.27 | 44.12 |
EV/EBIT |
13.42 | 14.59 | 26.92 | 43.87 | 0.00 | 9.20 | 8.88 | 7.89 | 18.97 | 0.00 |
Capex to Sales |
0.05 | 0.07 | 0.04 | 0.03 | 0.04 | 0.04 | 0.02 | 0.02 | 0.04 | 0.03 |
Price to Operating Income |
15.51 | 17.46 | 29.89 | 41.04 | 0.00 | 14.87 | 12.09 | 10.46 | 24.48 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.36 | 0.38 | 0.45 | 0.46 | 0.21 | 0.19 | 0.18 | 0.15 | 0.14 | 0.16 |
Cash ROIC |
4.42% | 10.59% | (0.49%) | 9.64% | (5.38%) | 4.73% | 12.04% | 4.69% | (0.37%) | (0.72%) |
Accounts Receivable Turnover |
6.04 | 6.08 | 4.61 | 3.23 | 2.93 | 5.02 | 4.43 | 3.59 | 3.70 | 3.18 |
Accounts Payable Turnover |
2.86 | 2.58 | 2.37 | 2.27 | 2.62 | 3.16 | 2.91 | 3.15 | 3.09 | 2.62 |
Inventory Turnover |
1.27 | 1.09 | 1.11 | 1.21 | 1.34 | 2.01 | 2.14 | 2.90 | 3.03 | 2.16 |
Average Days of Payables |
124.00 | 150.06 | 138.67 | 178.90 | 160.54 | 100.76 | 144.40 | 112.73 | 123.10 | 142.34 |
Days of Inventory on Hand |
297.97 | 316.19 | 371.08 | 303.82 | 335.67 | 178.96 | 203.46 | 146.59 | 108.72 | 166.42 |
Average Receivables |
29.88 | 26.47 | 30.90 | 40.00 | 35.33 | 26.56 | 28.73 | 31.89 | 27.82 | 24.40 |
Average Payables |
36.38 | 35.24 | 36.78 | 36.37 | 27.95 | 27.15 | 26.59 | 23.20 | 22.87 | 21.44 |
Average Inventory |
81.88 | 83.65 | 78.63 | 68.10 | 54.72 | 42.59 | 36.24 | 25.19 | 23.33 | 25.97 |
Average Assets |
375.48 | 363.58 | 338.64 | 320.52 | 264.67 | 192.23 | 155.96 | 130.11 | 110.90 | 100.84 |
Average Common Equity |
264.27 | 251.74 | 210.02 | 176.42 | 177.73 | 156.98 | 123.85 | 100.93 | 78.12 | 69.63 |
Columns are period end dates